PharmiWeb3h
Baxter Launches Next Generation of THE VEST for Airway Clearance
Baxter International Inc. (NYSE:BAX), a leading global medtech company, today unveiled its next generation airway clearance ...
PharmiWeb1h
Share price target 12.50 euros: Annual General Meeting supports SYNBIOTIC's growth plans with over 99 percent approval
AGM/EGMShare price target 12.50 euros: Annual General Meeting supports SYNBIOTIC's growth plans with over 99 percent approval 27.09.2024 / 11:19 CET/CESTThe issuer is solely responsible for the ...
PharmiWeb18h
Los Angeles Medical Waste Disposal Company Responds to Rise in Needlestick Injuries With In-Depth Guide
The CDC reports that healthcare workers in the U.S. face an estimated 385,000 needlestick and sharps-related injuries every ...
PharmiWeb23h
Natural Scientific Sparks a Revolution in the U.S. Supplement Market with 20 New All-Natural Products
In a wellness industry overflowing with options, one company is leading the charge toward a cleaner, more transparent future.
PharmiWeb21h
Pace Life Sciences Expands Capacity and Capability With Acquisition of Catalent’s Analytical Services Laboratory in Research Triangle Park
Company broadens service offerings and strengthens network by purchasing Catalent’s Center-of-Excellence for Small Molecule ...
PharmiWeb22h
Aesthetic Surgery Center Wins 1st Place in Three Categories in the 2024 Naples Community's Choice Awards
Aesthetic Surgery Center excels in Naples' 2024 Community's Choice Awards, earning top honors for its expertise in facial and ...
PharmiWeb3h
Formycon and Fresenius Kabi receive European Commission approval for FYB202/Otulfi® (ustekinumab) for the treatment of serious inflammatory diseases
Regulatory Approval/MiscellaneousFormycon and Fresenius Kabi receive European Commission approval for FYB202/Otulfi® (ustekinumab) for the treatment of serious inflammatory diseases 27.09.2024 / 09:00 ...
PharmiWeb5h
Hemogenyx Pharmaceuticals PLC Announces Half-year Report
LONDON, UNITED KINGDOM / ACCESSWIRE / September 27, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing therapies designed to transform blood disease treatment, ...
PharmiWeb9h
enVVeno Medical Corporation Announces Pricing of $15.0 Million Public Offering
IRVINE, CA / ACCESSWIRE / September 26, 2024 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, ...
PharmiWeb18h
Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results
Consolidated net revenue was $81.0 million versus $107.4 million in the prior year period. The change primarily reflects the Company's wind down of its Consumer Health Segment as part of the strategic ...
PharmiWeb1d
enVVeno Medical Corporation Announces Proposed Public Offering
IRVINE, CA / ACCESSWIRE / September 26, 2024 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, ...
PharmiWeb22h
Saint Therese Opens New Senior Living Community - Saint Therese of Corcoran - in Growing West Metro City of Corcoran
New Community will have Independent Living, Assisted Living and Memory Care apartments SAINT LOUIS PARK, MN / ACCESSWIRE / September 26, 2024 / Sixty years after its founding in 1964, Saint Therese ...